Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Multicellular organisms rely upon diverse and complex intercellular communications networks for a myriad of physiological processes. Disruption of these processes is implicated in the onset and propagation of disease and disorder, including the mechanisms of senescence at both cellular and organismal levels. In recent years, secreted extracellular vesicles (EVs) have been identified as a particularly novel vector by which cell-to-cell communications are enacted. EVs actively and specifically traffic bioactive proteins, nucleic acids, and metabolites between cells at local and systemic levels, modulating cellular responses in a bidirectional manner under both homeostatic and pathological conditions. EVs are being implicated not only in the generic aging process, but also as vehicles of pathology in a number of age-related diseases, including cancer and neurodegenerative and disease. Thus, circulating EVs—or specific EV cargoes—are being utilised as putative biomarkers of disease. On the other hand, EVs, as targeted intercellular shuttles of multipotent bioactive payloads, have demonstrated promising therapeutic properties, which can potentially be modulated and enhanced through cellular engineering. Furthermore, there is considerable interest in employing nanomedicinal approaches to mimic the putative therapeutic properties of EVs by employing synthetic analogues for targeted drug delivery. Herein we describe what is known about the origin and nature of EVs and subsequently review their putative roles in biology and medicine (including the use of synthetic EV analogues), with a particular focus on their role in aging and age-related brain diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling
Taylor, D. D., Akyol, S., & Gercel-Taylor, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1534 · Cited by 297 · cited 2×
“For example, exosomes derived from the placenta carry immunosuppressive FasL and UL-16 binding proteins that modulate the activity of maternal cytotoxic T and NK cell, respectively, inducing tolerance toward the foetus (Hedlund et al. 2009; Taylor et al. 2006).”
BackgroundRetractedJohnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931 · cited 4×
“One of the earliest insights into EV function dates back to the 1980s, when Johnstone and colleagues described EV secretion by sheep reticulocytes, suggesting that it could be a mechanism of protein clearance during reticulocyte maturation (Johnstone et al. 1987).”
BackgroundInfluentialLees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., & Ochiya, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107821 · Cited by 1,934 · cited 2×
“Several studies have evidenced successful loading of siRNAs and miRNAs into EVs with constructed vectors as well as utilizing transfection reagents (Olson et al. 2012; Zhang et al. 2010b; Kosaka et al. 2010; Ohno et al. 2013).”
BackgroundSyndecan–syntenin–ALIX regulates the biogenesis of exosomes
Baietti, M. F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., Ivarsson, Y., Depoortere, F., Coomans, C., Vermeiren, E., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2502 · Cited by 1,899
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Shedding microvesicles: artefacts no more
Cocucci, E., Racchetti, G., & Meldolesi, J. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.11.003 · Cited by 1,742
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.180 · Cited by 1,666
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485 · cited 2×
“a-Syn can be transferred between neurons, result in aggregation within the recipient neurons, inducing cell death (Desplats et al. 2009; Hansen et al. 2011; Emmanouilidou et al. 2010; Schneider and Simons 2013).”
BackgroundMechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.
Montecalvo, A., Larregina, A. T., Shufesky, W. J., Beer Stolz, D., Sullivan, M. L. G., Karlsson, J. M., Baty, C. J., Gibson, G. A., Erdos, G., Wang, Z., et al. (2012) · Blood · doi:10.1182/blood-2011-02-338004 · Cited by 1,429 · cited 2×
“Acid sphingomyelinases have also been implicated in microvesicle secretion, notably in glia following adenosine triphosphate (ATP) stimulation: upon ATP activation of the P2X7 receptor, acid sphingomyelinases relocate to the outer leaflet of the plasma membrane, immediately preceding microparticle…”
BackgroundAkers, J. C., Gonda, D., Kim, R., Carter, B. S., & Chen, C. C. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1084-8 · Cited by 1,423 · cited 2×
“While the description of EVs has historically been burdened by a Byzantine nomenclature (Gould and Raposo 2013), a systematic classification based on the mechanisms of biogenesis and release of EVs (Akers et al. 2013) allows for the categorization of EVs into four broad groups:”
BackgroundVesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation
Kalra, H., Simpson, R. J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V. C., Borràs, F. E., Breakefield, X., Budnik, V., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001450 · Cited by 1,367 · cited 2×
“The content of EVs EVs contain a broad range of molecules, primarily RNAs, proteins and lipids; according to Vesiclepedia (Kalra et al. 2012), a manually curated database of EV contents, 43,731 different proteins, 20,196 different mRNAs, 2,400 different microRNAs (miRNAs) and 342 different lipids have been described a…”
BackgroundZhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.164 · Cited by 1,356
Alzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343
Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells
Zwaal, R. F. A., & Schroit, A. J. (1997) · Blood · doi:10.1182/blood.v89.4.1121 · Cited by 1,340
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
Escola, J.-M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O., & Geuze, H. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20121 · Cited by 1,228
Emmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., & Vekrellis, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5699-09.2010 · Cited by 1,115 · cited 2×
“Exosomes are known to play a role in this intracellular transfer and propagation of a-Syn (Alvarez-Erviti et al. 2011a; Emmanouilidou et al. 2010; Schneider and Simons 2013) in an active, energy-dependent manner (Bellingham et al. 2012b; Aguzzi and Rajendran 2009).”
BackgroundExosomes: secreted vesicles and intercellular communications
Théry, C. (2011) · F1000 Biology Reports · doi:10.3410/b3-15 · Cited by 989
Saman, S., Kim, W., Raya, M., Visnick, Y., Miro, S., Saman, S., Jackson, B., McKee, A. C., Alvarez, V. E., Lee, N. C. Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277061 · Cited by 985
DePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951
Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943 · cited 1×
“It is also noteworthy that microvesicles isolated from the cere- brospinal fluid of AD patients exhibit some 60 miRNAs that are differentially expressed relative to healthy controls, however the significance of these specific markers has yet to be established (Cogswell et al. 2008).”
BackgroundKucharzewska, P., Christianson, H. C., Welch, J. E., Svensson, K. J., Fredlund, E., Ringnér, M., Mörgelin, M., Bourseau-Guilmain, E., Bengzon, J., & Belting, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220998110 · Cited by 939
Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing
Sebbagh, M., Renvoizé, C., Hamelin, J., Riché, N., Bertoglio, J., & Bréard, J. (2001) · Nature Cell Biology · doi:10.1038/35070019 · Cited by 915 · cited 2×
“On the other hand, EVs, as targeted intercellular shuttles of multipotent bioactive payloads, have demonstrated promising therapeutic properties, which can potentially be modulated and enhanced through cellular engineer- ing.”
BackgroundARF6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane Microvesicles
Muralidharan-Chari, V., Clancy, J., Plou, C., Romao, M., Chavrier, P., Raposo, G., & D'Souza-Schorey, C. (2009) · Current Biology · doi:10.1016/j.cub.2009.09.059 · Cited by 912 · cited 8×
“General markers of microvesicles are less welldefined, perhaps due to the diversity inherent in this class, but recently ADP-ribosylation factor 6 (ARF6) and vesicle-associated membrane protein 3 (VAMP3) have been proposed as potential candidates (Muralidharan-Chari et al. 2009).”
BackgroundInfluentialChristianson, H. C., Svensson, K. J., van Kuppevelt, T. H., Li, J.-P., & Belting, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304266110 · Cited by 903 · cited 1×
“…with the plasma membrane (Del Conde et al. 2005), while a recent work by Christianson et al. showed that heparan sulfate proteoglycans (HSPGs) act as receptors for cancer cell-derived exosomes and are required for their internalisation and function in the target cells (Christianson et al. 2013).”
BackgroundNeurotransmitter-Triggered Transfer of Exosomes Mediates Oligodendrocyte–Neuron Communication
Frühbeis, C., Fröhlich, D., Kuo, W. P., Amphornrat, J., Thilemann, S., Saab, A. S., Kirchhoff, F., Möbius, W., Goebbels, S., Nave, K.-A., et al. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001604 · Cited by 902
Exosomes are released by cultured cortical neurones
Fauré, J., Lachenal, G., Court, M., Hirrlinger, J., Chatellard-Causse, C., Blot, B., Grange, J., Schoehn, G., Goldberg, Y., Boyer, V., et al. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.12.003 · Cited by 896
Lee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877 · cited 4×
“Excess a-Syn secreted by neurons can be phagocytised by astrocytes and microglia in a putative waste clearance mechanism (Lee et al. 2010; Lee et al. 2008), however excessive accumulation in these recipient cells can lead to the formation of inclusions and trigger an inflammatory response…”
BackgroundInfluentialSelective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis
Fitzner, D., Schnaars, M., van Rossum, D., Krishnamoorthy, G., Dibaj, P., Bakhti, M., Regen, T., Hanisch, U.-K., & Simons, M. (2011) · Journal of Cell Science · doi:10.1242/jcs.074088 · Cited by 866
Hansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43366 · Cited by 842
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Circulating Exosomal microRNAs as Biomarkers of Colon Cancer
Ogata-Kawata, H., Izumiya, M., Kurioka, D., Honma, Y., Yamada, Y., Furuta, K., Gunji, T., Ohta, H., Okamoto, H., Sonoda, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092921 · Cited by 809
Biogenesis and Function of Multivesicular Bodies
Piper, R. C., & Katzmann, D. J. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123319 · Cited by 771 · cited 2×
“More- over, actin-myosin interactions seem to play a critical role in the formation of all four types of EVs described above (Gladnikoff et al. 2009; Piper and Katzmann 2007; Sebbagh et al. 2001; Muralidharan-Chari et al. 2009).”
BackgroundTakahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64463-x · Cited by 706
Membrane Microparticles: Two Sides of the Coin
Hugel, B., Martínez, M. C., Kunzelmann, C., & Freyssinet, J.-M. (2005) · Physiology · doi:10.1152/physiol.00029.2004 · Cited by 698
Yang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., Liu, Y., Huang, J.-D., & Song, E. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-117 · Cited by 693
Kooijmans, S. A. A., Stremersch, S., Braeckmans, K., de Smedt, S. C., Hendrix, A., Wood, M. J. A., Schiffelers, R. M., Raemdonck, K., & Vader, P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.014 · Cited by 663
Acid sphingomyelinase activity triggers microparticle release from glial cells
Bianco, F., Perrotta, C., Novellino, L., Francolini, M., Riganti, L., Menna, E., Saglietti, L., Schuchman, E. H., Furlan, R., Clementi, E., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.45 · Cited by 615
Xu, W., Ling, P., & Zhang, T. (2013) · Journal of Drug Delivery · doi:10.1155/2013/340315 · Cited by 595 · cited 3×
“…polymersomal EMV analogues (Akbarzadeh et al. 2013; Christian et al. 2009; Lee and Feijen 2012; Theresa and Pieter 2013), micelles (Deng et al. 2012; Xu et al. 2013), polymer, protein and lipid complexes (Zia ur et al. 2013; Wasungu and Hoekstra 2006; Ge et al. 2012; Zhang et al. 2012),…”
BackgroundInfluentialSpherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
Jensen, S. A., Day, E. S., Ko, C. H., Hurley, L. A., Luciano, J. P., Kouri, F. M., Merkel, T. J., Luthi, A. J., Patel, P. C., Cutler, J. I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006839 · Cited by 592 · cited 2×
“…siRNA targeting the oncoprotein Bcl2Like12, overexpressed in glioblastoma multiforme (GBM), effectively knocked down Bcl2L12 mRNA and protein in GBM cells and, when systemically administered to GBM xenografted mice, increased intratumoral apoptosis and decreased tumor burden (Jensen et al. 2013).”
BackgroundPark, J. E., Tan, H. S., Datta, A., Lai, R. C., Zhang, H., Meng, W., Lim, S. K., & Sze, S. K. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900381-mcp200 · Cited by 582 · cited 2×
“Thus, hypoxic conditions appear to drive cancer cells to modulate their microenvironments via microvesicle secretions, yielding a state more conducive to tumour growth and metastasis (Park et al. 2010).”
BackgroundQu, Y., Franchi, L., Nunez, G., & Dubyak, G. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1913 · Cited by 563
Exosomes for drug delivery—A novel application for the mesenchymal stem cell
Lai, R. C., Yeo, R. W. Y., Tan, K. H., & Lim, S. K. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.08.008 · Cited by 546 · cited 4×
“Advances in synthetic biology and genetic engineering will further progress our ability to evolve and develop these therapeutic delivery platforms with tailored contents and targeting, but current applications of natural exosomes are limited (Koppers-Lalic et al. 2013; Kosaka et al. 2013; Lai et al. 2013; Munoz et al.…”
BackgroundInfluentialDinkins, M. B., Dasgupta, S., Wang, G., Zhu, G., & Bieberich, E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.012 · Cited by 494 · cited 2×
“On the other hand, neuron- and astrocyte-derived exosomes have been demonstrated to promote aggregation of monomeric Ab into insoluble plaques, suggesting that the parent cell-dependent lipid composition may influence an EV’s effect on Ab aggregation (Dinkins et al. 2014; Yuyama et al. 2008).”
BackgroundValenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A., Corbelli, A., Fais, S., Parmiani, G., & Rivoltini, L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1819 · Cited by 493 · cited 5×
“Furthermore, tumour-derived exosomes are known to impair the capacity of CD14? monocytes to differentiate into functional DCs, leading to an abundance of CD14? cells with low levels of expressed human leukocyte antigen-DR (HLA-DR) that serve as myeloid suppressor cells (Valenti et al. 2006).”
BackgroundInfluentialThe Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids
Aguzzi, A., & Rajendran, L. (2009) · Neuron · doi:10.1016/j.neuron.2009.12.016 · Cited by 473
Assembly-dependent endocytosis and clearance of extracellular a-synuclein
Lee, H.-J., Suk, J.-E., Bae, E.-J., Lee, J.-H., Paik, S. R., & Lee, S.-J. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.017 · Cited by 470
Schwann cell‐derived exosomes enhance axonal regeneration in the peripheral nervous system
Lopez‐Verrilli, M. A., Picou, F., & Court, F. A. (2013) · Glia · doi:10.1002/glia.22558 · Cited by 453 · cited 2×
“Similarly, dedifferentiated Schwann cells are found to secrete exosomes, which are taken up selectively by dorsal root ganglia axons, enhancing regeneration in injury models (Lopez-Verrilli et al. 2013).”
BackgroundTrans-Synaptic Transmission of Vesicular Wnt Signals through Evi/Wntless
Korkut, C., Ataman, B., Ramachandran, P., Ashley, J., Barria, R., Gherbesi, N., & Budnik, V. (2009) · Cell · doi:10.1016/j.cell.2009.07.051 · Cited by 443 · cited 2×
“Furthermore, EVs have been shown to regulate the synaptic transfer of Wnt morphogens at the neuromuscular junction (Korkut et al. 2009), hinting at a potential role in broader Wnt-mediated developmental processes.”
BackgroundEndothelial microparticles in diseases
Chironi, G. N., Boulanger, C. M., Simon, A., Dignat-George, F., Freyssinet, J.-M., & Tedgui, A. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0710-9 · Cited by 420
Potolicchio, I., Carven, G. J., Xu, X., Stipp, C., Riese, R. J., Stern, L. J., & Santambrogio, L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2237 · Cited by 365 · cited 2×
“…and Court 2012), neural stem/progenitor cells (Huttner et al. 2008; Marzesco et al. 2005), microglia (Bianco et al. 2005; Bianco et al. 2009; Potolicchio et al. 2005; Tamboli et al. 2010), oligodendrocytes (Fitzner et al. 2011; Hsu et al. 2010; Trajkovic et al. 2008) and endothelial cells…”
BackgroundCancer and aging: a model for the cancer promoting effects of the aging stroma
Krtolica, A., & Campisi, J. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00053-5 · Cited by 295
Svensson, K. J., Kucharzewska, P., Christianson, H. C., Sköld, S., Löfstedt, T., Johansson, M. C., Mörgelin, M., Bengzon, J., Ruf, W., & Belting, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104261108 · Cited by 288
Preparation and brain delivery property of biodegradable polymersomes conjugated with ox26
Pang, Z., Lu, W., Gao, H., Hu, K., Chen, J., Zhang, C., Gao, X., Jiang, X., & Zhu, C. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.007 · Cited by 264
The enterocyte microvillus is a vesicle-generating organelle
McConnell, R. E., Higginbotham, J. N., Shifrin, D. A., Tabb, D. L., Coffey, R. J., & Tyska, M. J. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200902147 · Cited by 260
Theunis, C., Crespo-Biel, N., Gafner, V., Pihlgren, M., López-Deber, M. P., Reis, P., Hickman, D. T., Adolfsson, O., Chuard, N., Ndao, D. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072301 · Cited by 259 · cited 1×
“…peptides mimicking pathological epitopes of Ab or Tau with the intent of eliciting a robust and specific antibody response against the toxic form of the peptide and a subsequent clinical improvement in disease models (Hickman et al. 2011; Muhs et al. 2007; Nicolau et al. 2002; Theunis et al. 2013).”
BackgroundRole of Pancreatic Cancer-derived Exosomes in Salivary Biomarker Development
Lau, C., Kim, Y., Chia, D., Spielmann, N., Eibl, G., Elashoff, D., Wei, F., Lin, Y.-L., Moro, A., Grogan, T., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452458 · Cited by 256
Boller, K., König, H., Sauter, M., Mueller-Lantzsch, N., Löwer, R., Löwer, J., & Kurth, R. (1993) · Virology · doi:10.1006/viro.1993.1487 · Cited by 188
Spuch, C., & Navarro, C. (2011) · Journal of Drug Delivery · doi:10.1155/2011/469679 · Cited by 177 · cited 2×
“Most applications of liposomes in the treatment of PD are symptomatic, with efforts devoted to developing optimal pharmacokinetics of L-DOPA and analogues (Spuch and Navarro 2011; Di Stefano et al. 2006).”
BackgroundTaylor, M., Moore, S., Mourtas, S., Niarakis, A., Re, F., Zona, C., Ferla, B. L., Nicotra, F., Masserini, M., Antimisiaris, S. G., et al. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.06.015 · Cited by 149 · cited 1×
“…as putative AD therapeutics, with a common approach being the use of the vesicle to target (via specific membrane lipids, antibodies or curcumin) and sequester potentially toxic extracellular Ab (Bereczki et al. 2011; Canovi et al. 2011; Gobbi et al. 2010; Taylor et al. 2011; Mourtas et al. 2011).”
BackgroundDewannieux, M., Blaise, S., & Heidmann, T. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15573-15577.2005 · Cited by 137
Bieda, K., Hoffmann, A., & Boller, K. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-3-591 · Cited by 113
Retroviral Assembly and Budding Occur through an Actin-Driven Mechanism
Gladnikoff, M., Shimoni, E., Gov, N. S., & Rousso, I. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.08.016 · Cited by 101 · cited 4×
“On the other hand, EVs, as targeted intercellular shuttles of multipotent bioactive payloads, have demonstrated promising therapeutic properties, which can potentially be modulated and enhanced through cellular engineer- ing.”
BackgroundInfluentialMueller-Lantzsch, N., Sauter, M., Weiskircher, A., Kramer, K., Best, B., Buck, M., & Grässer, F. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.343 · Cited by 98 · cited 2×
“Retrovirus-like particles are less well studied, though Gag protein (together with other endogenous viral proteins) may be a general marker (Bronson et al. 1979; Boller et al. 1993; Mueller-Lantzsch et al. 1993; Dewannieux et al. 2005).”
BackgroundMartínez, M. C., & Freyssinet, J.-M. (2001) · BMC Cell Biology · doi:10.1186/1471-2121-2-20 · Cited by 54
Cited by
Exosomes as novel bio-carriers for gene and drug delivery
Jiang, X.-C., & Gao, J.-Q. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.038 · Cited by 321
Iraci, N., Leonardi, T., Gessler, F., Vega, B., & Pluchino, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020171 · Cited by 301
Self-citationEitan, E., Green, J., Bodogai, M., Mode, N. A., Bæk, R., Jørgensen, M. M., Freeman, D. W., Witwer, K. W., Zonderman, A. B., Biragyn, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01386-z · Cited by 271
Leggio, L., L'Episcopo, F., Magrì, A., Ulloa‐Navas, M. J., Paternò, G., Vivarelli, S., Bastos, C. A. P., Tirolo, C., Testa, N., Caniglia, S., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201203 · Cited by 54
Self-citationDluzen, D. F., Noren Hooten, N., & Evans, M. K. (2017) · WIREs RNA · doi:10.1002/wrna.1385 · Cited by 31
Metadata
- Authors
- Smith, J. A., Leonardi, T., Huang, B., Iraci, N., Vega, B., & Pluchino, S.
- Venue
- Biogerontology
- Published
- 2014-06-28
- Volume
- 16
- Issue
- 2
- Pages
- 147-185
- ISSN
- 1389-5729 (ISSN-L)
- 1573-6768
- OpenAlex
- W2089910800
- Cited by
- 54
- References
- 66
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.